How is CRPS treated, and what does the evidence say?

Complex regional pain syndrome (CRPS) is treated with physical and occupational therapy, pain relief, education and psychological care together, with nerve blocks or implanted stimulators for some people. A 2023 Cochrane overview of 17 systematic reviews found no high-certainty evidence for any CRPS treatment. Guidelines still recommend starting rehabilitation early.

A painted apothecary bottle and mortar with a poppy and lupine.

What is the main treatment for CRPS?

The main treatment for complex regional pain syndrome is rehabilitation that restores use of the limb, supported by pain relief, education and psychological care. The Royal College of Physicians' 2018 guideline names four pillars of care, "education, pain relief, physical rehabilitation and psychological intervention," and says they "have equal importance." The 2022 practical guidelines in Pain Medicine place functional restoration by an interdisciplinary team at the core of CRPS treatment.

Medication, nerve blocks and implanted devices play a supporting role in both guidelines. A 2015 review in The BMJ by Bruehl described their purpose as "to facilitate engagement in functional therapies." The Royal College of Physicians states that there is no proven cure for CRPS.

How strong is the evidence for CRPS treatments?

The evidence for most CRPS treatments is weak. A 2023 Cochrane overview by Ferraro and colleagues examined five Cochrane reviews and twelve other systematic reviews and "found no high-certainty evidence for any comparison." For a wide range of commonly used treatments, the overview reported that "the certainty in the evidence was very low and provides insufficient evidence to either support or refute their use."

Weak evidence does not show that a CRPS treatment fails. The Cochrane overview found that the trials "were typically small and mostly at high risk of bias." The tables on this page name one main study or review for each treatment and state how strong the evidence is. A certainty rating describes how much confidence reviewers place in a result.

What does the evidence say about therapy and psychological care for CRPS?

Rehabilitation therapies for CRPS are recommended first by every guideline and rest on small trials.

Rehabilitation and psychological treatments for CRPS: main study and evidence strength
TreatmentWhat the main study or guideline foundEvidence strength
Physical and occupational therapyCochrane review, 2022 (Smart): 34 trials left the effect on CRPS pain and disability "very uncertain"Very low certainty; first-line in guidelines
Graded motor imageryMoseley, 2006: in 51 patients with CRPS type I or phantom limb pain, pain fell 23.4 mm against 10.5 mm with usual careLow to very low; one research team
Mirror therapyMcCabe, 2003: pain relief in CRPS of 8 weeks or less and no change in chronic CRPS, in 8 patientsVery low; pilot study
DesensitizationRecommended by the 2018 and 2022 guidelines; no randomized trial identifiedClinical opinion (level 4)
Exposure therapyden Hollander, 2016: exposure reduced disability more than usual care at 6 months in 46 CRPS patientsVery low certainty (Cochrane, 2022)
Psychological care for CRPSOne of four pillars in the 2018 guideline; trials come mostly from other chronic painLow for CRPS specifically

What does the evidence say about pills and creams for CRPS?

Most oral and topical medications used for CRPS have one small CRPS trial or none.

Oral and topical medications used for CRPS, with the main study and evidence strength
MedicationWhat the main study or guideline foundEvidence strength
CorticosteroidsChristensen, 1982: all 13 patients on prednisone improved more than 75 percent, against 2 of 10 on placeboLow; small trial in early disease
Gabapentinvan de Vusse, 2004: a crossover trial in CRPS type I reported "a mild effect on pain"Low
Tricyclic antidepressants and SNRIs for CRPSThe 2023 Cochrane overview found no randomized trial of tricyclic antidepressants in CRPSBorrowed from other nerve pain
Opioids for CRPSOne trial of controlled-release morphine found no difference from placebo after 8 days (2022 guidelines)No supporting trial
Topical DMSO 50 percent creamZuurmond, 1996: greater improvement than placebo cream over 2 months in 32 patients with acute CRPSLow
Low-dose naltrexone for CRPSChopra, 2013: a report of two patientsVery low; case reports

What does the evidence say about infusions for CRPS?

Three infusion treatments for CRPS have been tested against placebo. Two showed short-term pain relief and one showed none.

Infusion treatments for CRPS, with the main study and evidence strength
InfusionWhat the main study foundEvidence strength
BisphosphonatesFerraro, 2026: across 11 trials and 754 participants, CRPS pain was 10.0 points lower on a 0 to 100 scale between 4 weeks and 3 monthsLow certainty; short-term
Ketaminevan den Brink, 2026: across 21 studies and 605 patients, CRPS pain fell 3.6 points on a 0 to 10 scale within 14 days, then returned toward baseline by 90 daysLow to moderate; short-term
Low-dose immunoglobulin (IVIG)Goebel, 2017: no benefit over placebo in 108 patients with CRPS of 1 to 5 yearsModerate, against benefit

What does the evidence say about nerve blocks, stimulators and surgery for CRPS?

Procedures, implanted devices and surgery for CRPS, with the main study and evidence strength
ProcedureWhat the main study or review foundEvidence strength
Sympathetic nerve blockCochrane overview, 2023: lidocaine sympathetic blockade "probably does not reduce pain intensity compared with placebo"Moderate, against benefit
Spinal cord stimulationKemler, 2000: in a 54-patient trial, CRPS pain fell 2.4 cm at 6 months with stimulation; by 5 years results were similar to physical therapy aloneOne randomized trial
Dorsal root ganglion stimulationDeer, 2017: 81.2 percent had at least 50 percent relief of leg CRPS pain at 3 months, against 55.7 percent with spinal cord stimulationOne trial; lower limb only
Intrathecal baclofen pumpvan Rijn, 2009: CRPS dystonia and pain improved at 12 months in 36 patients, with 89 adverse eventsLow
SympathectomyCochrane review, 2013 (Straube): one eligible study, of 20 participants, and no comparison with a sham procedureVery low
AmputationBodde, 2011: in a review of 26 case series, CRPS recurred in the stump in 31 of 65 casesCase series only

Are CRPS medications approved by the FDA for CRPS?

The medications used for CRPS are prescribed off label. The National Institute of Neurological Disorders and Stroke states that the medicines "are used 'off label' to treat CRPS. This means they are approved for other conditions." The 2022 practical guidelines name Food and Drug Administration approvals only for other conditions, such as carbamazepine for trigeminal neuralgia. A 2022 article published by the American Society of Regional Anesthesia and Pain Medicine describes off-label use of ketamine as "common and supported by evidence-based medicine." The medications guide covers each drug class.

Does starting CRPS treatment early matter?

Guidelines call for early treatment of CRPS. The Royal College of Physicians' 2018 guideline says physiotherapy or occupational therapy "should be initiated immediately when CRPS is suspected." The National Institute of Neurological Disorders and Stroke says treatment is usually most effective when it is started early. The 2022 practical guidelines add that most people with early CRPS improve and that approximately 15 percent fail to recover.

Can CRPS be prevented after a fracture?

Vitamin C after a wrist fracture has been tested for preventing CRPS, with conflicting results. Zollinger's 2007 trial of 416 patients found CRPS in 2.4 percent with vitamin C and 10.1 percent with placebo. Ekrol's 2014 trial of 336 patients found no benefit. The 2022 practical guidelines call the value of vitamin C "unproven." The full account is in preventing CRPS after a fracture.

How does CRPS treatment evidence matter in a California injury claim?

A California injury claim can include the cost of future CRPS treatment. The Judicial Council's jury instruction CACI No. 3903A requires the injured person to prove "the reasonable cost of reasonably necessary medical care" that the person "is reasonably certain to need in the future." Treating doctors and a life care plan supply that proof, and insurers commonly challenge treatments that rest on weak trials.

Guides in this section

Common questions

The Royal College of Physicians' 2018 guideline states that there is no proven cure for CRPS. The 2022 practical guidelines in Pain Medicine advise doctors to tell patients that "there is no treatment proven to cure CRPS or reduce symptoms in all patients," and that the available drugs have helped some patients. Treatment aims to reduce pain and restore use of the limb. The same guidelines note that patients with early CRPS will likely improve naturally.

Guidelines put physical and occupational therapy first. The Royal College of Physicians' 2018 guideline says therapy should begin immediately when CRPS is suspected, with gentle movement, light functional activity and desensitization. The same guideline has the treating team start simple pain medicines, which may ease injury-related pain and help the person move the limb. Medications for nerve pain and referral to a pain clinic follow if pain persists.

No CRPS treatment has high-certainty evidence, according to the 2023 Cochrane overview. Among medications, bisphosphonates have the most placebo-controlled trials. A 2026 meta-analysis in Annals of Internal Medicine pooled 11 trials with 754 participants and found a 10-point pain reduction on a 100-point scale between four weeks and three months, rated low certainty, with little to no difference at other time points.

CRPS is uncommon, so trials enroll few patients. The 2023 Cochrane overview reported that the studies in its included reviews "were typically small and mostly at high risk of bias or of low methodological quality." The overview also found no randomized trial evidence for routinely used drugs such as tricyclic antidepressants and opioids. Its authors concluded that an evidence-based approach to CRPS will remain difficult until larger trials are done.

Not always. In Sigtermans' 2009 trial of ketamine in 60 patients with CRPS type I, the authors reported "significant pain relief without functional improvement." In Kemler's 2000 trial of spinal cord stimulation in 54 patients, pain fell and "there was no clinically important improvement in functional status." Guidelines treat pain relief as a way to make rehabilitation possible, and rehabilitation as the route to using the limb again.

A 2018 study by Elsamadicy and colleagues examined insurance claims for 35,316 United States patients with a new CRPS diagnosis. The median total cost of care was $8,508 in the year of diagnosis, and the median cumulative cost over the eight years after diagnosis was $43,026. Those figures are amounts insurers paid for typical coded patients. They are not estimates for severe cases. See what CRPS treatment costs.

ClinicalTrials.gov, the registry run by the National Library of Medicine, lists CRPS studies and the sites where each one is recruiting. The California CRPS trial finder on this site reads that registry and shows the studies with California locations. A listing does not mean a study suits a particular person. The study team and the person's own doctor decide eligibility.

Sources

Every source below was opened and read for this page. The date is when it was last checked.

  1. Complex Regional Pain Syndrome: Practical Diagnostic and Treatment Guidelines, 5th EditionClinical guideline · Pain Medicine (Harden et al.), 2022 · checked
  2. Complex regional pain syndrome in adults: UK guidelines for diagnosis, referral and management in primary and secondary care, 2nd editionClinical guideline · Royal College of Physicians, 2018 · checked
  3. Complex Regional Pain SyndromeGovernment agency · National Institute of Neurological Disorders and Stroke · checked
  4. Interventions for treating pain and disability in adults with complex regional pain syndrome: an overview of systematic reviewsStudy · Cochrane Database of Systematic Reviews (Ferraro et al.), 2023 · checked
  5. Complex regional pain syndromeStudy · The BMJ (Bruehl), 2015 · checked
  6. Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and IIStudy · Cochrane Database of Systematic Reviews (Smart et al.), 2022 · checked
  7. Graded motor imagery for pathologic pain: a randomized controlled trialStudy · Neurology (Moseley), 2006 · checked
  8. A controlled pilot study of the utility of mirror visual feedback in the treatment of complex regional pain syndrome (type 1)Study · Rheumatology (McCabe et al.), 2003 · checked
  9. Expose or protect? A randomized controlled trial of exposure in vivo vs pain-contingent treatment as usual in patients with complex regional pain syndrome type 1Study · Pain (den Hollander et al.), 2016 · checked
  10. Efficacy and Safety of Bisphosphonates for Complex Regional Pain Syndrome: A Systematic Review and Meta-analysisStudy · Annals of Internal Medicine (Ferraro et al.), 2026 · checked
  11. The reflex dystrophy syndrome response to treatment with systemic corticosteroidsStudy · Acta Chirurgica Scandinavica (Christensen et al.), 1982 · checked
  12. Randomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1Study · BMC Neurology (van de Vusse et al.), 2004 · checked
  13. Treatment of acute reflex sympathetic dystrophy with DMSO 50% in a fatty creamStudy · Acta Anaesthesiologica Scandinavica (Zuurmond et al.), 1996 · checked
  14. Treatment of Complex Regional Pain Syndrome (CRPS) using low dose naltrexone (LDN)Study · Journal of Neuroimmune Pharmacology (Chopra and Cooper), 2013 · checked
  15. Intravenous ketamine for complex regional pain syndrome: Pain outcomes and predictors of response. A systematic review and meta-analysisStudy · The Journal of Pain (van den Brink et al.), 2026 · checked
  16. Low-Dose Intravenous Immunoglobulin Treatment for Long-Standing Complex Regional Pain Syndrome: A Randomized TrialStudy · Annals of Internal Medicine (Goebel et al.), 2017 · checked
  17. Spinal cord stimulation in patients with chronic reflex sympathetic dystrophyStudy · The New England Journal of Medicine (Kemler et al.), 2000 · checked
  18. Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trialStudy · Journal of Neurosurgery (Kemler et al.), 2008 · checked
  19. Dorsal root ganglion stimulation yielded higher treatment success rate for complex regional pain syndrome and causalgia at 3 and 12 months: a randomized comparative trialStudy · Pain (Deer et al.), 2017 · checked
  20. Intrathecal baclofen for dystonia of complex regional pain syndromeStudy · Pain (van Rijn et al.), 2009 · checked
  21. Cervico-thoracic or lumbar sympathectomy for neuropathic pain and complex regional pain syndromeStudy · Cochrane Database of Systematic Reviews (Straube et al.), 2013 · checked
  22. Therapy-resistant complex regional pain syndrome type I: to amputate or not?Study · The Journal of Bone and Joint Surgery, American Volume (Bodde et al.), 2011 · checked
  23. Can vitamin C prevent complex regional pain syndrome in patients with wrist fractures? A randomized, controlled, multicenter dose-response studyStudy · The Journal of Bone and Joint Surgery, American Volume (Zollinger et al.), 2007 · checked
  24. The influence of vitamin C on the outcome of distal radial fractures: a double-blind, randomized controlled trialStudy · The Journal of Bone and Joint Surgery, American Volume (Ekrol et al.), 2014 · checked
  25. Prevalence and Cost Analysis of Complex Regional Pain Syndrome (CRPS): A Role for NeuromodulationStudy · Neuromodulation (Elsamadicy et al.), 2018 · checked
  26. Judicial Council of California Civil Jury Instructions (CACI), 2026 editionJury instruction · Judicial Council of California, 2026 · checked
  27. ClinicalTrials.gov study registry and APIDataset · U.S. National Library of Medicine · checked
  28. Ketamine Infusion Therapy and Its Role in Chronic PainOrganization · ASRA Pain Medicine News (Goordeen et al.), 2022 · checked
  29. Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1Study · Pain (Sigtermans et al.), 2009 · checked

Ask a lawyer about your CRPS case

Free case review. No fee unless we recover. A person from Wise Law reads every message.

What happened before the CRPS started? (optional)
Has a doctor diagnosed CRPS? (optional)
Or call (424) 235-7879

Submitting this form does not create an attorney-client relationship. An attorney-client relationship is formed only by a signed written fee agreement.

Text usCall